MARKET COMPOSITE
CGC - Canopy Growth Corporation8:00:00 PM 4/15/2024
Price
$6.98
-0.82 (-10.51%)
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis for recreational and medical purposes primarily in Canada, the United States, Germany, and the United Kingdom. It operates through two segments, Cannabis, Hemp and Other Consumer Products; and Canopy Rivers. The company's products include dried cannabis flowers, oils and concentrates, and softgel capsules. It offers its products under the Tweed, Quatreau, Deep Space, Spectrum Therapeutics, First & Free, TWD, This Works, BioSteel, DNA Genetics CraftGrow, Tokyo Smoke, DOJA, Van der Pop, and Bean & Bud brands. The company also provides growth capital and a strategic support platform that pursues investment opportunities in the global cannabis sector. Canopy Growth Corporation has a clinical research partnership with NEEKA Health Canada and NHL Alumni Association to examine the efficacy of CBD-based therapies as part of the mitigation of persistent post-concussion symptoms. As of February 14, 2020, it operated 28 cannabis retail stores under the Tweed or Tokyo Smoke name. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.
Stock Chart

Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from 

Finra

Moving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.

Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.

Stock news

    Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (Nasdaq: CGC) today announced the voting results from its special meeting of shareholders held on Friday, April 12, 2024 (the "Meeting").

    Key Takeaways; Cannabis Sector Canopy Growth received ISS recommendation for creation of exchangeable shares. Trulieve to hold first quarter 2024 results conference call at the beginning of May. Goodness Growth announced sale of Vireo Health of New York in effort to address financial constraints. Avant Brands entered German market through IM Cannabis deal. Key Takeaways; […]

    Several cannabis stocks — Tilray (TLRY), Canopy Growth Corp. (CGC), Aurora (ACB) — are taking off after the Florida Supreme Court approves an amendment on recreational marijuana use to be on the ballot this November in the 2024 presidential election. Yahoo Finance Live reports on what legalization could mean for Florida's market, citing projections from Trulieve (TCNNF). For more expert insight and the latest market action, click here to watch this full episode of Market Domination. Editor's not...

    Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (Nasdaq: CGC) is pleased to announce that Institutional Shareholder Services ("ISS"), in its report issued on Canopy Growth's special meeting of shareholders scheduled for April 12, 2024, has recommended that Canopy Growth shareholders (the "Canopy Shareholders") vote in favor of the previously announced special resolution authorizing an amendment to the Company's articles of incorporation, as amended (the "Amendment Propos

    Cannabis-related stocks such as Tilray Brands (TLRY), Canopy Growth (CGC), Aurora Cannabis (ACB) jumped on news out of Canada and Germany. In Canada, a government group brought together to study the impacts of the legalization legislation recommends the country reduce the excise taxes producers have to pay. Meanwhile, Germany has decriminalized cannabis for personal use. Yahoo Finance's Josh Lipton and Julie Hyman discuss the moves in the video above. For more expert insight and the latest marke...

    Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (Nasdaq: CGC), a world-leading diversified cannabis company, celebrates the German government's final approval legalizing cannabis, as well as advancing a clear victory for enhanced medical cannabis access.

    Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (Nasdaq: CGC) today announced that independent proxy advisory firm Glass Lewis & Co. ("Glass Lewis"), in its report issued on Canopy Growth's special meeting of shareholders scheduled for April 12, 2024, recommended that Canopy Growth shareholders (the "Canopy Shareholders") vote in favour of the previously announced special resolution authorizing an amendment to the Company's articles of incorporation, as amended (the "Ame

    Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (Nasdaq: CGC) today announced additional details with respect to the previously announced special resolution to be voted on by the shareholders of Canopy Growth (the "Canopy Shareholders") authorizing an amendment to the Company's articles of incorporation, as amended (the "Amendment Proposal"), in order to: (i) create and authorize the issuance of an unlimited number of a new class of non-voting and non-participating excha

    Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (Nasdaq: CGC), a world-leading diversified cannabis company, today announced the introduction of five new pre-roll products across the Company's adult-use cannabis portfolio from brands 7ACRES and Hiway.

    Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (Nasdaq: CGC) announced today that the Company will hold a special meeting (the "Meeting") of shareholders at 1:00PM ET on Friday, April 12, 2024. The Meeting will be conducted in virtual format by live audio webcast at: